Report #2899207

Received Jun 5, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: MA
Recovered: Unknown
Vaccinated: Jan 1, 2026
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	947353	—

Symptoms (1)

Incomplete course of vaccination

Symptom narrative

A Patient Received A 1st Dose 4 Months Ago And Needs The Second Dose; Initial report received on 22-May-2026. A pharmacist reported that a 38-year-old female (race and ethnicity not provided) received the first dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and had not received the second dose yet. No medical history or concomitant medications were reported. In Jan-2026, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (Lot #947353, expiration date, NDC #, route and site not reported)]. At the time of reporting, approximately four months after having been vaccinated with HEPLISAV-B, the patient has not had their second dose yet. No adverse events were reported. No additional information was reported. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.